Announced
Financials
Tags
Pharmaceuticals
Pending
Acquisition
Cross Border
Friendly
Public
United States
biopharmaceuticals
Private Equity
Single Bidder
Minority
Synopsis
G42, a health-tech company, agreed to acquire a minority stake in vTv Therapeutics, a clinical stage biopharmaceutical company, for $25m. “We have a deep commitment to collaborating with international organizations to share our knowledge and expertise in the consumer and clinical health spectrum and we look forward to working together with vTv to further develop and commercialize this important treatment. As we move ahead, we will continue to join forces with the world’s best to innovate and invest in science and create the next wave of medicines to future-proof the health of nations,” Fahed Al Marzooqi, G42 Healthcare Chief Operating Officer.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.